What is Methergine?
Methergine, also known by its generic name methylergonovine maleate, is a medication used to prevent or control heavy bleeding after childbirth [1]. It works by causing contractions of the uterus, which helps to reduce blood loss [1].
How is Methergine Used?
Methergine is typically administered by a healthcare professional after delivery of the placenta [1]. It can be given intravenously, intramuscularly, or orally [1]. The dosage and duration of treatment depend on the individual patient's needs and response [1].
What are the Risks and Side Effects of Methergine?
Common side effects of Methergine can include nausea, vomiting, abdominal pain, headache, dizziness, and temporary shortness of breath [1]. More serious side effects, though rare, can include high blood pressure, seizures, chest pain, and allergic reactions [1]. It is important for patients to inform their healthcare provider of any pre-existing medical conditions, such as high blood pressure or heart disease, before taking Methergine [1].
When Does Methergine Patent Exclusivity End?
Information regarding specific patent expiry dates for Methergine is not readily available in the provided context. DrugPatentWatch.com offers a resource for tracking patent information for various medications [2].
Are There Alternatives to Methergine?
Other medications and methods can be used to manage postpartum hemorrhage. These may include oxytocin (Pitocin), prostaglandins, and surgical interventions, depending on the cause and severity of the bleeding [3]. Your healthcare provider will determine the most appropriate treatment plan for your specific situation.